<DOC>
	<DOCNO>NCT02990767</DOCNO>
	<brief_summary>The aim study develop algorithm base combination maternal factor , uterine artery PI , MAP serum biomarkers estimate patient-specific risk early Preeclampsia ( PE ) evaluate screen performance algorithm twin .</brief_summary>
	<brief_title>Prediction Early Pre-eclampsia From Maternal Factors , Biophysical Biochemical Markers First Trimester</brief_title>
	<detailed_description>Preeclampsia ( PE ) still lead cause fetal maternal morbidity mortality incidence 3-5 % worldwide . Despite intensive research effort pathogenesis disease still unknown likely multifactorial.Clinical risk factor traditionally use identify woman high risk develop preeclampsia , biophysical factor may help predict hypertensive disorder pregnancy.In addition , change serum concentration angiogenic antiangiogenic factor imply pathogenesis PE possible relevance diagnosis disease .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<criteria>twin pregnancy deliver phenotypically normal stillbirth live birth 24 week gestation . twin pregnancy 1114 week gestation pregnancy major fetal abnormality end termination , miscarriage fetal death 24 week</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>